# Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study

Study · id `cardio:ct-nct02409238` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02409238](<https://clinicaltrials.gov/study/NCT02409238>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02409238

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 105 participants.

## Technical summary

Registry record NCT02409238. Randomized; no masking; primary purpose treatment. Start 2015-03-11 (actual); primary completion 2019-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT02409238, source copy `cardio:ctgov-nct02409238-2023-01-11`, retrieved 2026-10-26)
- Started: 2015-03-11 (actual) (ClinicalTrials.gov record NCT02409238, source copy `cardio:ctgov-nct02409238-2023-01-11`, retrieved 2026-10-26)
- Primary completion: 2019-12-31 (actual) (ClinicalTrials.gov record NCT02409238, source copy `cardio:ctgov-nct02409238-2023-01-11`, retrieved 2026-10-26)
- Completion: 2019-12-31 (actual) (ClinicalTrials.gov record NCT02409238, source copy `cardio:ctgov-nct02409238-2023-01-11`, retrieved 2026-10-26)
- Countries: Singapore (ClinicalTrials.gov record NCT02409238, source copy `cardio:ctgov-nct02409238-2023-01-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02409238-2023-01-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study
- Acronym: IRMCI
- Condition: Mild Cognitive Impairment
- Condition: Insulin Resistance
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): Metformin
- Intervention (Behavioral): Intensive Lifestyle Intervention
- Intervention (Behavioral): Standard LIfestyle Recommendation
- Lead sponsor: SingHealth Polyclinics
- Lead sponsor class: OTHER
- Collaborator: National University of Singapore
- Collaborator class: OTHER
- Collaborator: Singapore General Hospital
- Collaborator class: OTHER
- Collaborator: Changi General Hospital
- Collaborator class: OTHER
- Collaborator: National University Hospital, Singapore
- Collaborator class: OTHER
- Collaborator: Singapore Clinical Research Institute
- Collaborator class: OTHER
- Collaborator: Agency for Science, Technology and Research
- Collaborator class: OTHER
- Collaborator: Khoo Teck Puat Hospital
- Collaborator class: OTHER
- Collaborator: Duke-NUS Graduate Medical School
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: SingHealth Polyclinics (`cardio:org-singhealth-polyclinics`)
- Registry lists this organization as a collaborator: National University of Singapore (`cardio:org-national-university-of-singapore`)
- Registry lists this organization as a collaborator: Singapore General Hospital (`cardio:org-singapore-general-hospital`)
- Registry lists this organization as a collaborator: Changi General Hospital (`cardio:org-changi-general-hospital`)
- Registry lists this organization as a collaborator: National University Hospital, Singapore (`cardio:org-national-university-hospital-singapore`)
- Registry lists this organization as a collaborator: Singapore Clinical Research Institute (`cardio:org-singapore-clinical-research-institute`)
- Registry lists this organization as a collaborator: Agency for Science, Technology and Research (`cardio:org-agency-for-science-technology-and-research`)
- Registry lists this organization as a collaborator: Khoo Teck Puat Hospital (`cardio:org-khoo-teck-puat-hospital`)
- Registry lists this organization as a collaborator: Duke-NUS Graduate Medical School (`cardio:org-duke-nus-graduate-medical-school`)

## Provenance

Content hash: 70e12db1498a20f24199b3ca42241d8cf78f91213be85bb77a723e1d3792c4b1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
